MAPT and Cognitive impairment: There was no difference in tau deposition between regions with different Braak stages comparing TREM2 p.R47H carriers and non-carriers with mild cognitive impairment, except for higher deposition in the Braak stage VI region in TREM2 p.R47H carriers.